Perrigo buys CanAm Care

Deal to help Perrigo enter $1.5 billion diabetes market

ALLEGAN, Mich. — Drug maker Perrigo is buying a privately owned distributor of diabetes products, the company said Monday.

Perrigo announced the $36 million acquisition of Alpharetta, Ga.-based CanAm Care, whose assets include Dex4 hypoglycemia products, insulin delivery syringes and pen needles, lancing, wound care and compression stockings.

"This acquisition — alongside the store-brand glucose monitoring meters and strips powered by OnSync launched in 2011 with AgaMatrix — showcases our continued commitment to providing a comprehensive line of quality, affordable health care to the growing diabetes community," Perrigo chairman and CEO Joseph Papa said.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

Login or Register to post a comment.